Editorial Lp(a) – the underestimated cardiovascular risk factor

por Mellwig, Klaus-Peter
Publicado 2017

Lipoprotein (a) and coronary heart disease – is there an efficient secondary prevention?

por Mellwig, Klaus-Peter, Horstkotte, Dieter, van Buuren, Frank
Publicado 2017

HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures

por Buuren, Frank van, Kreickmann, Sven, Horstkotte, Dieter, Kottmann, Tanja, Mellwig, Klaus Peter
Publicado 2012

Incidence of elevated lipoprotein (a) levels in a large cohort of patients with cardiovascular disease

por van Buuren, Frank, Horstkotte, Dieter, Knabbe, Cornelius, Hinse, Dennis, Mellwig, Klaus Peter
Publicado 2017

COVID-19 in German Competitive Sports: Protocol for a Prospective Multicenter Cohort Study (CoSmo-S)

por Niess, Andreas Michael, Widmann, Manuel, Gaidai, Roman, Gölz, Christian, Schubert, Isabel, Castillo, Katty, Sachs, Jan Philipp, Bizjak, Daniel, Vollrath, Shirin, Wimbauer, Fritz, Vogel, Azin, Keller, Karsten, Burgstahler, Christof, Quermann, Anne, Kerling, Arno, Schneider, Gerald, Zacher, Jonas, Diebold, Katharina, Grummt, Maximilian, Beckendorf, Claudia, Buitenhuis, Johannes, Egger, Florian, Venhorst, Andreas, Morath, Oliver, Barsch, Friedrich, Mellwig, Klaus-Peter, Oesterschlink, Julian, Wüstenfeld, Jan, Predel, Hans-Georg, Deibert, Peter, Friedmann-Bette, Birgit, Mayer, Frank, Hirschmüller, Anja, Halle, Martin, Steinacker, Jürgen Michael, Wolfarth, Bernd, Meyer, Tim, Böttinger, Erwin, Flechtner-Mors, Marion, Bloch, Wilhelm, Haller, Bernhard, Roecker, Kai, Reinsberger, Claus
Publicado 2022